Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
- Department for International Development
- 1 January 2009
- Document Type:
- Evaluation Report
- Cox, J., Stevens, G., Tarragona-Fiol, T., Hural, J., Cleland, N. Denny, T., Needham, L., Ozaki, D., Rodriguez-Chavez, I.R., Sarzotti-Kelsoe, M., Simkins, A., and Stiles, T.
This paper addresses for the first time an attempt to harmonize Good Clinical Laboratory Practice (GCLP) approaches into a single set of recommendations for optimal operations and management that can be followed by clinical laboratories, not only in the HIV field, but also possibly in other science and medical fields.
Cleland, N.; Cox, J.; Denny, T.; Hural, J.; Needham, L.; Ozaki, D.; Rodriguez-Chavez, I.R.; Sarzotti-Kelsoe, M.; Simkins, A.; Stevens, G.; Stiles, T.; Tarragona-Fiol, T. Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I&#8211;III Clinical Trials. PLoS Medicine (2009) 6 (5) e1000067. [DOI: 10.1371/journal.pmed.1000067]
Published: 1 January 2009